Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: Combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival;Erratum: Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: Combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. [BMC Cancer. 15, (2015) (441)] DOI: 10.1186/s12885-015-1446-z

BMC Cancer

Volumn 16, Issue 1, 2016, Pages

  Hald, Sigurd M ^a   Kiselev, Yury ^a   Al Saad, Samer ^a,b   Richardsen, Elin ^a,b   Johannessen, Charles ^a   Eilertsen, Marte ^a   Kilvaer, Thomas K ^b   Al Shibli, Khalid ^a,c   Andersen, Sigve ^a,b   Busund, Lill Tove ^a,b   Bremnes, Roy M ^a,b   Donnem, Tom ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c NORDLAND HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR;

EID: 84997282742     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1446-z     Document Type: Article

References (1)

1. Hald SM, et al. Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. BMC Cancer. 2015;15:441. doi: 10.1186/s12885-015-1446-z.